RESUMO
An existing USP(2010) impurity method for levothyroxine drug substance was modified to expand its applicability for the analysis of levothyroxine oral solution (OS) formulation while achieving desirable resolution between the components of OS formulation. When analyzed using modified USP(2010) method, an unknown impurity was detected in one of the levothyroxine OS products. A systematic investigation of unknown impurity was carried out using a combination of chromatographic, mass spectral and physicochemical methods to understand the nature of this unknown impurity. A possible elucidation of chemical structure and reaction mechanism for the formation of this previously unreported impurity was proposed.
Assuntos
Contaminação de Medicamentos , Tiroxina , Cromatografia Líquida de Alta PressãoRESUMO
BACKGROUND: Determination of vaginal distribution is important to the development of potential vaginal microbicidal or spermicidal products. STUDY DESIGN: This was a descriptive study of three imaging techniques with a randomized crossover assignment of two gels and activity status within each technique. METHOD: Each of three sites utilized one technique. Three nulligravid women and three parous women were to be enrolled at each site. We studied the effects of time, ambulation, parity and body mass index on vaginal spreading of two commonly used gels, K-Y Jelly and Replens. Imaging by magnetic resonance imaging and gamma scintigraphy was performed at 5, 20, 35 and 50 min after insertion of 3.5 mL of gel. Imaging with a fiberoptic probe was performed at 5 and 20 min after insertion. RESULTS: Initial application of the gel resulted in approximately two thirds of maximum coverage possible, both in linear extent along the vaginal axis and in surface area covered. Over the next 45 min, spreading increased to about three quarters of the maximum possible. Ambulation generally increased linear spreading and the proportions of women with gel at the introitus and os. Effects of parity and body mass index (BMI) were similar on most measures of gel spreading, with nulligravid women tending toward greater spread than parous women and women of high BMI usually showing somewhat greater spread than women of normal weight. Differences between the two gels were not seen when all conditions of application were considered together. CONCLUSION: In vivo imaging of gel distribution demonstrated that ambulation, parity and BMI affect vaginal gel spreading. The three imaging techniques have advantages and disadvantages and provide complementary information for microbicide development.
Assuntos
Celulose/análogos & derivados , Emolientes/farmacocinética , Glicerol/farmacocinética , Fosfatos/farmacocinética , Propilenoglicóis/farmacocinética , Vagina/metabolismo , Administração Intravaginal , Adulto , Índice de Massa Corporal , Celulose/administração & dosagem , Celulose/farmacocinética , Colposcopia/métodos , Estudos Cross-Over , Emolientes/administração & dosagem , Feminino , Tecnologia de Fibra Óptica , Glicerol/administração & dosagem , Humanos , Lipídeos/administração & dosagem , Lipídeos/farmacocinética , Imageamento por Ressonância Magnética , Paridade , Fosfatos/administração & dosagem , Gravidez , Propilenoglicóis/administração & dosagem , Cintilografia , Fatores de Tempo , Distribuição Tecidual , Vagina/diagnóstico por imagem , Cremes, Espumas e Géis Vaginais/farmacocinética , CaminhadaRESUMO
The present work was carried out to study the deposition patterns and clearance of technetium-99m (99mTc) DTPA labeled cromolyn sodium (CS) solutions when administered from two different CS nasal products using gamma scintigraphy. Five healthy volunteers received a single dose with complete crossover design involving treatment A (test formulation) and treatment B (reference formulation). The deposition patterns as well as the changes in distribution of the radiolabeled CS solutions due to the mucociliary transport were monitored by gamma scintigraphy. Primary deposition of the aforementioned nasal solutions occurred in the anterior portion of the nose. After migration into the posterior nasal cavity, the solutions were rapidly cleared by ciliary action into the nasopharynx where it was swallowed. The test product of cromolyn sodium was shown to be equivalent to the reference product with regard to nasal deposition and clearance. The results from this study indicate that external gamma scintigraphy can be used to demonstrate the equivalence of nasal sprays that are intended for local therapeutic action where the drug is not systemically absorbed into the blood circulation. Furthermore, a non-invasive imaging method such as rhinoscintigraphy may prove to be a useful technique to be utilized during the regulatory approval process for local-acting nasal products, and may facilitate the early introduction of these products to the market.
Assuntos
Antiasmáticos/administração & dosagem , Antiasmáticos/farmacocinética , Cromolina Sódica/administração & dosagem , Cromolina Sódica/farmacocinética , Cavidade Nasal/diagnóstico por imagem , Cavidade Nasal/metabolismo , Absorção , Administração Intranasal , Adulto , Aerossóis , Química Farmacêutica , Estudos Cross-Over , Relação Dose-Resposta a Droga , Humanos , Marcação por Isótopo , Masculino , Mucosa Nasal/diagnóstico por imagem , Mucosa Nasal/metabolismo , Cintilografia , Compostos Radiofarmacêuticos , Pentetato de Tecnécio Tc 99m , Equivalência TerapêuticaRESUMO
The purpose of this study was to investigate a potential nucleophilic addition mechanism in aqueous apomorphine formulation solutions in the presence of widely used antioxidants such as sodium metabisulfite (Na2S2O5). The findings of this investigation provide insights into how sodium metabisulfite can influence the formation of particulate under the conditions leading to the auto-oxidation of apomorphine to apomorphine orthoquinone. The addition products resulting from the reaction of bisulfite nucleophile on apomorphine orthoquinone in a Michael addition fashion were identified and characterized using ultraviolet-visible spectroscopy and mass spectrometry.
Assuntos
Antioxidantes/química , Apomorfina/química , Agonistas de Dopamina/química , Composição de Medicamentos/métodos , Sulfitos/química , Benzoquinonas/química , Excipientes/química , Oxirredução , Espectrometria de Massas por Ionização por Electrospray , Água/químicaRESUMO
The absorption and distribution of iodinated derivatives of nonoxynol-9, after vaginal administration in rats, were compared with results reported for [14C] nonoxynol-9. Mono-iodinated nonoxynol-9 was synthesized in addition to the radiolabeled derivative incorporating iodide-125 ([125I]). Six hours after dosing, test rats were euthanized and selected tissues were excised and assessed for radioactivity. Levels of radioactive markers in the reproductive system were substantial for both [14C] and [125I]. It was concluded that [125I] mono-iodinated nonoxynol-9 and [14C] nonoxynol-9 possessed similar bioavailability.
Assuntos
Radioisótopos de Carbono/farmacocinética , Radioisótopos do Iodo/farmacocinética , Nonoxinol/síntese química , Nonoxinol/farmacocinética , Administração Intravaginal , Animais , Disponibilidade Biológica , Radioisótopos de Carbono/administração & dosagem , Radioisótopos de Carbono/química , Feminino , Radioisótopos do Iodo/administração & dosagem , Radioisótopos do Iodo/química , Marcação por Isótopo , Nonoxinol/administração & dosagem , Especificidade de Órgãos , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/síntese química , Compostos Radiofarmacêuticos/farmacocinética , Ratos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Distribuição TecidualRESUMO
This study was designed to examine the kinetics of decomposition of paclitaxel 2'-N-methylpyridinium mesylate (PNMM), a derivative of paclitaxel. Further, the potential for PNMM to act as a prodrug of paclitaxel was assessed in vitro. Stability studies of PNMM were conducted over a pH range of 4.0 to 8.0 at 25 degrees C. The critical micelle concentration (CMC) of PNMM was determined by pulsating bubble surfactometry. Studies of the conversion of PNMM to paclitaxel were conducted in vitro in human plasma. Decomposition of PNMM followed apparent zero-order kinetics. The pH-rate profile exhibited no evidence of acid catalysis down to pH 4.0, while the rate was accelerated under base conditions. Surface tension studies suggested that PNMM formed micelles with a CMC of approximately 34 micro g/mL. Conversion studies in phosphate buffer showed that no more than 5% of PNMM converted to paclitaxel, while in human plasma the conversion was about 25%. The degradation of PNMM was via apparent zero-order kinetics and was dependent upon pH. The observed apparent zero-order kinetics of decomposition of PNMM was consistent with the formation of micelles in phosphate buffer. In buffered aqueous media alone or in human plasma, PNMM did not convert quantitatively to paclitaxel. Thus, the limiting factor in the application of PNMM as a prodrug would appear to be the poor potential to convert to paclitaxel.
Assuntos
Antineoplásicos/metabolismo , Paclitaxel/farmacocinética , Pró-Fármacos/metabolismo , Antineoplásicos/química , Química Farmacêutica , Estabilidade de Medicamentos , Cinética , Mesilatos/química , Paclitaxel/química , Pró-Fármacos/química , SolubilidadeRESUMO
The aim of this study was to test the hypothesis that polyvinylpyrrolidone (PVP) would increase the critical micelle concentration (CMC) of nonoxynol-9 (N-9), providing a reduction in its irritation potential, while maintaining essential spermicidal activity. Solid coprecipitates of N-9 with PVP were manufactured with the use of a modified lyophilization process. The irritation potential of N-9 was estimated by an in vitro assay, monitoring the extent of hemolysis of red blood cells. CMCs of N-9 were measured in the presence of various concentrations of PVP. A modified Sander-Cramer assay was implemented to measure the spermicidal activity of N-9 and the N-9/PVP coprecipitates. With the use of the lyophilization process and more suitable solvents, solid coprecipitates of N-9/PVP were manufactured with no residual organic solvents. The irritation potential of N-9 was reduced when in the presence of PVP-50% hemolysis values increased from 0.054 mM to more than 0.2mM. N-9 CMC values increased in the presence of PVP from 0.085 mM (0% PVP) to 0.110 mM (3.5% PVP) and 0.16 6mM (10% PVP). However, spermicidal activities ranged from 0.213 mM to 0.238 mM, N-9 remaining steady regardless of the amount of PVP. By use of N-9/PVP coprecipitates, the self-association properties and irritation potentials of N-9 were altered. This result suggests a process to produce a spermicidal product that reduces the detrimental implications to the vaginal epithelium while maintaining the essential spermicidal activity.
Assuntos
Nonoxinol/química , Povidona/química , Animais , Bioensaio , Precipitação Química , Cães , Eritrócitos/efeitos dos fármacos , Feminino , Hemólise/efeitos dos fármacos , Humanos , Irritantes/administração & dosagem , Irritantes/efeitos adversos , Irritantes/antagonistas & inibidores , Masculino , Micelas , Nonoxinol/administração & dosagem , Nonoxinol/efeitos adversos , Excipientes Farmacêuticos/química , Excipientes Farmacêuticos/uso terapêutico , Povidona/uso terapêutico , Espermicidas/administração & dosagem , Espermicidas/efeitos adversos , Espermicidas/química , Espermatozoides/metabolismo , Vaginite/etiologia , Vaginite/prevenção & controleRESUMO
PURPOSE: [corrected] To evaluate the in vivo disintegration behavior of tablets and capsules of a bile acid sequestrant, DMP 504, in beagle dogs and to assess the significance of the in vitro disintegration of the dosage forms on subsequent in vivo behavior in order to draw possible in vitro-in vivo correlations. METHODS: Tablet and capsule formulations of a bile acid sequestrant, DMP 504, were formulated with samarium oxide and neutron activated to produce radioactive 53Sm to noninvasively evaluate their in vivo behavior in beagle dogs by gamma-scintigraphy. A four-way crossover design was completed (n = 4) in which (a) tablets from two different batches were administered under the fasted condition and manufactured using different lots of drug substance where one batch exhibited relatively faster in vitro disintegration time (30 min) than the other tablet batch, which resulted in slower disintegration (45 min), (b) a capsule formulation was administered to fasted beagles, and (c) the tablet having slower in vitro disintegration was also administered in the fed state, and its in vivo disintegration was compared to that observed in the fasted state. RESULTS: Tablets manufactured using a lot of DMP 504 having relatively fast in vitro disintegration (approximately 30 min) resulted in relatively rapid in vivo disintegration time (15 min) in the fasted condition. This in vivo disintegration time was comparable to the in vivo disintegration of the capsules (17 min) even though the in vitro capsule disintegration time was considerably faster (2 min). Tablets prepared using a drug substance that provided a longer in vitro disintegration time (approximately 45 min) resulted in a slower in vivo disintegration (63 min). There was no difference observed in the in vivo disintegration behavior in fasted and fed dogs for the tablets that provided slower in vitro disintegration. CONCLUSION: In vivo disintegration of tablets of the bile acid sequestrant DMP 504 correlated with in vitro disintegration times. Gamma-Scintigraphy continues to be a good tool to use during early stages of product development to investigate in vivo performance of dosage forms. The results of this study provided evidence that the physical chemical specifications of the drug substance may not always be indicative of in vitro or in vivo performance of tablet dosage form, even when formulation and process are not changed.